Literature DB >> 571302

Content and subcellular localization of catecholamines and 5-hydroxytryptamine in human and animal blood platelets: monoamine distribution between platelets and plasma.

M Da Prada, G B Picotti.   

Abstract

1 The content of adrenaline (Ad), noradrenaline (NA) and dopamine was measured in human, guinea-pig, cat, rabbit and rat blood platelets by a highly sensitive and specific radioenzymatic method.2 In all platelet specimens analyzed, the content of the three catecholamines (CA) was several thousand times lower than that of 5-hydroxytryptamine (5-HT).3 In basal conditions, the NA concentration in platelets and plasma always exceeded that of Ad and dopamine.4 In rat and rabbit platelets, Ad, NA and dopamine were present only in the free (unconjugated) form.5 Platelets of rats with storage pool deficiency (Fawn-hooded) contained much less 5-HT and CA than normal rat platelets.6 Following restraint stress, platelets of Fawn-hooded rats, in contrast to normal rat platelets, did not accumulate CA in spite of a dramatic rise in plasma CA.7 Reserpine, a monoamine depletor, released CA as well as 5-HT from rabbit platelets in vivo.8 Subcellular fractionation experiments with rabbit platelets indicate that both CA and 5-HT are most concentrated in the fraction consisting of pure 5-HT organelles.9 Both in humans and rabbits the concentration gradient between platelets and plasma was much lower for CA than for 5-HT, indicating that a high affinity transport mechanism operates in vivo for 5-HT but not for CA.10 In conclusion, the present data show that both human and animal platelets contain Ad, NA and dopamine. The bulk of the CA seems to be stored as unconjugated amines together with 5-HT, histamine and p-octopamine in a multitransmitter storage site, namely the 5-HT organelle.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 571302      PMCID: PMC1668670          DOI: 10.1111/j.1476-5381.1979.tb07878.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

1.  The association of adrenaline and noradrenaline with blood platelets.

Authors:  H WEIL-MALHERBE; A D BONE
Journal:  Biochem J       Date:  1958-09       Impact factor: 3.857

2.  The mechanism of serotonin and catecholamine uptake by platelets.

Authors:  F B HUGHES; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1959-10       Impact factor: 4.030

3.  The fluorimetric estimation of adrenaline and noradrenaline in plasma.

Authors:  H WEIL-MALHERBE; A D BONE
Journal:  Biochem J       Date:  1957-09       Impact factor: 3.857

4.  Binding of serotonin and other amines by blood platelets.

Authors:  H WEISSBACH; D F BOGDANSKI; S UDENFRIEND
Journal:  Arch Biochem Biophys       Date:  1958-02       Impact factor: 4.013

5.  Identification and assay of serotonin in brain.

Authors:  D F BOGDANSKI; A PLETSCHER; B B BRODIE; S UNDENFRIEND
Journal:  J Pharmacol Exp Ther       Date:  1956-05       Impact factor: 4.030

6.  Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue.

Authors:  C DE DUVE; B C PRESSMAN; R GIANETTO; R WATTIAUX; F APPELMANS
Journal:  Biochem J       Date:  1955-08       Impact factor: 3.857

7.  Serotonin release as a possible mechanism of reserpine action.

Authors:  A PLETSCHER; P A SHORE; B B BRODIE
Journal:  Science       Date:  1955-08-26       Impact factor: 47.728

8.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

9.  The uptake of adrenaline and noradrenaline by blood platelets of the pig.

Authors:  G V BORN; O HORNYKIEWICZ; A STAFFORD
Journal:  Br J Pharmacol Chemother       Date:  1958-12

10.  Plasma adrenaline, noradrenaline and dopamine in man and different animal species.

Authors:  H U Bühler; M da Prada; W Haefely; G B Picotti
Journal:  J Physiol       Date:  1978-03       Impact factor: 5.182

View more
  19 in total

Review 1.  Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma.

Authors:  Thamara E Osinga; Thera P Links; Robin P F Dullaart; Karel Pacak; Anouk N A van der Horst-Schrivers; Michiel N Kerstens; Ido P Kema
Journal:  FASEB J       Date:  2017-03-06       Impact factor: 5.191

2.  Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenaline.

Authors:  D M Vanags; S E Rodgers; E M Duncan; J V Lloyd; F Bochner
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

3.  Characterization of an endothelial 5-hydroxytryptamine (5-HT) receptor mediating relaxation of the porcine coronary artery.

Authors:  G J Molderings; G Engel; E Roth; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-09       Impact factor: 3.000

4.  Platelets and biogenic amines. 2. Indications for a discrete low affinity uptake mechanism shared by norepinephrine and 5-hydroxytryptamine in human platelets.

Authors:  R Malmgren
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Specific correction of impaired acid hydrolase secretion in storage pool-deficient platelets by adenosine diphosphate.

Authors:  B Lages; C A Dangelmaier; H Holmsen; H J Weiss
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

6.  The effects of the 5 HT2 antagonist ketanserin in adult atopic asthma.

Authors:  D J Stott; J A Roberts; N C Thomson; S G Ball
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

7.  Dissipation mechanisms for 5-hydroxytryptamine in the coronary circulation of the isolated perfused heart of the rat.

Authors:  L J Bryan; S R O'Donnell; A M Williams
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

8.  Plasma serotonin levels are associated with antidepressant response to SSRIs.

Authors:  Amanda Holck; Owen M Wolkowitz; Sindy H Mellon; Victor I Reus; J Craig Nelson; Åsa Westrin; Daniel Lindqvist
Journal:  J Affect Disord       Date:  2019-02-26       Impact factor: 4.839

9.  Liberation of catecholamines and 5-hydroxytryptamine from human blood-platelets.

Authors:  M Peyer; A Pletscher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-02       Impact factor: 3.000

10.  Serotonin and noradrenaline concentrations and serotonin uptake in platelets from hyperphenylalaninaemic patients.

Authors:  M Giovannini; R Valsasina; R Longhi; A M Cesura; M D Galva; E Riva; G P Bondiolotti; G B Picotti
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.